Pacific Biosciences of California Inc (PACB): Street Finally Waking Up
Currently, there are 267.74M common shares owned by the public and among those 251.67M shares have been available to trade. The company’s stock has a 5-day price change of -17.83% and -57.75% over the past three months. PACB shares are trading -71.10% year to date (YTD), with the 12-month market performance down to -75.33% lower. […]
Gains May Be On The Menu For Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 267.74M common shares owned by the public and among those 251.64M shares have been available to trade. However, the script later moved the day high at 4.5650, up 4.64%. The company’s stock has a 5-day price change of 5.87% and -52.87% over the past three months. PACB shares are trading -63.20% year […]
Pacific Biosciences of California Inc (NASDAQ: PACB): Hunting Genuine Value In Market Debris
Currently, there are 267.74M common shares owned by the public and among those 251.64M shares have been available to trade. The company’s stock has a 5-day price change of -0.82% and -64.77% over the past three months. PACB shares are trading -62.79% year to date (YTD), with the 12-month market performance down to -61.90% lower. […]
Look At Analyst Expectations For A Better Read On Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 267.74M common shares owned by the public and among those 251.64M shares have been available to trade. The company’s stock has a 5-day price change of -3.30% and -65.04% over the past three months. PACB shares are trading -64.12% year to date (YTD), with the 12-month market performance down to -63.37% lower. […]
Gains May Be On The Menu For Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 267.74M common shares owned by the public and among those 252.00M shares have been available to trade. However, the script later moved the day high at 3.8550, down -0.82%. The company’s stock has a 5-day price change of -9.23% and -61.44% over the past three months. PACB shares are trading -62.90% year […]
Pacific Biosciences of California Inc (NASDAQ: PACB) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 267.74M common shares owned by the public and among those 252.00M shares have been available to trade. The company’s stock has a 5-day price change of -9.84% and -47.49% over the past three months. PACB shares are trading -55.15% year to date (YTD), with the 12-month market performance down to -49.83% lower. […]
Analyst Expect Big Moves From Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 267.74M common shares owned by the public and among those 252.04M shares have been available to trade. Insiders at the company have transacted a total of 10 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 2 of these insider trades were purchases, […]
Pacific Biosciences of California Inc (PACB): Street Finally Waking Up
Currently, there are 267.44M common shares owned by the public and among those 254.98M shares have been available to trade. Insiders at the company have transacted a total of 19 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
Growing Through Challenges? – Pacific Biosciences of California Inc (PACB)
Currently, there are 267.44M common shares owned by the public and among those 253.36M shares have been available to trade. Insiders at the company have transacted a total of 19 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
Pacific Biosciences of California Inc (NASDAQ: PACB) – Suitable For Long Term Buy?
Currently, there are 267.44M common shares owned by the public and among those 256.44M shares have been available to trade. Insiders at the company have transacted a total of 21 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
